Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Med Food ; 22(8): 789-796, 2019 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-31329014

RESUMEN

Royal jelly (RJ) is widely used as a cosmetic or dietary supplement to relieve various health disorders, such as dry skin, fatigue, and menopause. RJ has been recommended to improve constipation on a commercial basis. However, the detailed mechanisms by which RJ influences intestinal motility and whether RJ improves constipation remain unclear. Therefore, we investigated the effects of RJ on the motility of mouse ileum both in vitro and in vivo. Using myograph methods, RJ dose-dependently induced contractions of isolated ileal segments, which were inhibited by treatment with atropine. Eserine sulfate, a cholinesterase inhibitor, enhanced the RJ-induced contractions, whereas RJ treated with acetylcholinesterase did not result in ileum contraction. RJ-induced contractions were not affected by NG-nitro-l-arginine methyl ester, a nitric oxide synthase inhibitor, although nicotine-induced contractions were significantly enhanced. In contrast, in a gastrointestinal (GI) transit model, single oral administration of 300 mg/kg RJ did not affect GI transit in both normal mice and the loperamide-induced constipation model mice. These results demonstrate that acetylcholine in RJ directly acted on the muscarinic receptors of the mouse intestinal smooth muscle, causing it to contract in vitro. In contrast, single oral administration of RJ did not improve constipation. This study is the first to evaluate the effects of RJ on the motility of mouse ileum in in vitro and in vivo experiments for the validation of application of RJ as a gentle laxative.


Asunto(s)
Ácidos Grasos/farmacología , Motilidad Gastrointestinal/efectos de los fármacos , Íleon/fisiopatología , Acetilcolina/metabolismo , Animales , Estreñimiento/tratamiento farmacológico , Estreñimiento/metabolismo , Estreñimiento/fisiopatología , Humanos , Íleon/efectos de los fármacos , Íleon/metabolismo , Técnicas In Vitro , Laxativos/farmacología , Masculino , Ratones , Ratones Endogámicos ICR
2.
J Pharm Pharmacol ; 63(8): 1015-21, 2011 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-21718284

RESUMEN

OBJECTIVES: The aim of this study was to use time-lapse confocal laser scanning microscopy to establish a more sensitive and specific method for evaluating P-glycoprotein activity in Caco-2 cells. METHODS: The change in the fluorescence of residual rhodamine 123 at the apical and central regions of Caco-2 cells was measured in the presence of digoxin or St John's wort by using time-lapse confocal laser scanning microscopy. The data were compared with measurements made using conventional techniques, a fluorescence microplate reader and a fluorescence microscope. KEY FINDINGS: The percentage decrease of rhodamine 123 caused by 10 µm digoxin or 0.1 µg/ml St John's wort was significantly larger in the apical region of the Caco-2 cell than in the central region or in the whole cell. The digoxin-induced inhibition in the apical region as measured by time-lapse confocal laser scanning microscopy was greater than that measured in the whole cell by a microplate reader or a fluorescence microscope. CONCLUSIONS: The assay of residual rhodamine 123 in the apical region of Caco-2 cells by confocal laser scanning microscopy was more sensitive than the conventional methods using a microplate reader or fluorescence microscopy. It will be a valuable screening tool for studying both the inhibition and induction of P-glycoprotein activity.


Asunto(s)
Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/metabolismo , Transporte Biológico/fisiología , Células CACO-2/metabolismo , Interacciones Farmacológicas/fisiología , Microscopía Confocal/métodos , Transporte Biológico/efectos de los fármacos , Digoxina/farmacología , Colorantes Fluorescentes/metabolismo , Humanos , Hypericum , Extractos Vegetales/farmacología , Rodamina 123/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA